Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,729.52
(
-0.03%
)
News Focus
News Focus
Post# of 257661
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

go seek

Send PM Follow Ignore
Followers 23
Posts 5156
Boards Moderated 0
Alias Born 06/24/2006

go seek

Re: None

Sunday, 10/01/2006 11:51:38 PM

Sunday, October 01, 2006 11:51:38 PM

Post# of 257661
IDIX – NM283 releases at AASLD: 1) 24-week (interim) data from phase-2b in naïve patients; 2) 48-week (final) data in phase-2b refractory patients.

In my AASLD search, I could not find info on 48-week (final) data in phase-2b refractory patients. Perhaps I missed (???)

The creation of a thousand forests is in one acorn.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today